Lataa...
Injectable interferon beta-1b for the treatment of relapsing forms of multiple sclerosis
Multiple sclerosis (MS) is chronic inflammatory and demyelinating disease with either a progressive (10%–15%) or relapsing-remitting (85%–90%) course. The pathological hallmarks of MS are lesions of both white and grey matter in the central nervous system. The onset of the disease is usually around...
Tallennettuna:
| Päätekijä: | |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Dove Medical Press
2010
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3218739/ https://ncbi.nlm.nih.gov/pubmed/22096354 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|